Quote:
Thereafter, we may, from time to time and at our sole discretion, direct Oasis to purchase up to the lesser of (i) 200% of the average daily trading volume of our common stock for the ten prior trading days or (ii) and $500,000 of our common stock on any business day, provided the lowest traded price of our common stock in the five prior trading days exceeds $0.01. Except as described in this prospectus, there are no trading volume requirements or restrictions under the Oasis Purchase Agreement, and we will control the timing and amount of any sales of our common stock to Oasis.

So I guess they can sell as soon as the shares are registered. Also, GNBT can not sell more than $500K value of shares on any given day, so it will be spread over 2-3 weeks if they wanted to sell 14M+ shares in the trauch.

Quote:
Although the Oasis Purchase Agreement provides that we may sell up to $40,000,000 of our common stock to Oasis, only 15,542,133 shares of our common stock that may be issued and sold to Oasis under the Oasis Purchase Agreement are being offered under this prospectus, which represents (i) the 1,228,501 Commitment Shares that we issued to Oasis as a commitment fee, and (iii) an additional 14,313,632 shares which may be issued to Oasis in the future under the Oasis Purchase Agreement.

(0)

(0)

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.